Abstract: A method for modifying a gliadin and an application thereof are provided. The method includes the following steps: dissolving the gliadin in a solvent to obtain gliadin solution; and adding a proline endoprotease to the gliadin solution for a reaction, and adjusting the pH value of solution to neutral according to a gradient, to obtain a modified gliadin. The modified gliadin obtained by the present invention may be uniformly dispersed in water, and may still maintain a uniform dispersion state in the water after high-temperature thermal sterilization and long-term storage, or even in the presence of sodium chloride, it has good thermal stability, salt resistance, and storage stability.

Abstract: Provide is a wearable device comprising at least two electrodes and a wearable structure. The at least two electrodes are configured to fit against the skin of a human body to collect an electrocardiogram (ECG) signal of the human body, and the wearable structure is configured to carry the at least two electrodes and fit the at least two electrodes to a waist region of the human body. The at least two electrodes are spaced apart on the wearable structure, and disposed on two sides of a mid-sagittal plane of the human body when the human body wears the wearable structure.

Abstract: A use of lactoferrin in the preparation of a food or drug, the food or drug being used for activating a VDR signaling pathway, which is used for the treatment of bone disease, bone disease comprising: osteoporosis, bone damage, loss of bone calcium, incomplete bone development and bone abnormalities. The present invention further comprises screening for drugs that are used to promote osteoblast proliferation and differentiation by using an active state of the VDR signaling pathway.

Abstract: Embodiments of the present disclosure provide a signal acquisition system including a wearable body; a plurality of electrodes fixed on the wearable body and in contact with the skin of a user, and a processing circuit. The plurality of electrodes include a first electrode set and a second electrode set, and the first electrode set is configured to acquire a physiological signal and the second electrode set is configured to acquire a detection signal. The processing circuit configured to eliminate, based on the detection signal, motion artifacts in the physiological signal.

Abstract: A cell growth promoter and an application thereof are provided. The invention adopts Fe2+ and ovalbumin to form a Fe2+-ovalbumin (OVA) compound to promote ovalbumin cell endocytosis, the cell growth promoter can maintain cell growth in an environment free of amino acids, promote cell proliferation in an environment with amino acids; and, the Fe2+-OVA compound can replace expensive animal serum albumin in cell culture, the cell growth promoter has a significant effect on improving cell viability and is low cost.

Abstract: An electrocardio monitoring system and method are provided. The electrocardio monitoring system includes at least two sets of electrocardio channels and a processing circuit. Each of the at least two sets of electrocardio channels includes at least two electrodes, and each of the at least two sets of electrocardiographic channels is configured to collect signals from a human body through the at least two electrodes, respectively. The processing circuit is configured to extract the electrocardio signal from the signals collected by the at least two sets of electrocardiographic channels.

Abstract: A magnetic recording head includes an active component and a piezoelectric actuator. The active component is disposed proximal to a media-facing surface of the magnetic recording head. The piezoelectric actuator includes a piezoelectric layer, a first electrode coupled to the piezoelectric layer, and a second electrode coupled to the piezoelectric layer. The piezoelectric actuator is configured to exert a mechanical force to displace the active component such that the displacement changes a protrusion of the active component from the media-facing surface.

Abstract: Provided are a method for manufacturing a molded composite inductor, and a molded composite inductor. The method includes: putting a plurality of conductors apart from each other into a mold, and extending two ends of each of the plurality of conductors out of the mold; filling the mold with magnetic powder such that the magnetic powder covers the plurality of conductors, and applying pressure to the magnetic powder such that the magnetic powder forms a magnetic body and is integrated with the plurality of conductors to form an inductor module.

Abstract: The present application relates to an internally embedded copper plate-type soft magnetic powder core inductor, a preparation method therefor, and a use thereof. The internally embedded copper plate-type soft magnetic powder core inductor comprises a copper plate, a surface of the copper plate is covered with a soft magnetic material, and an interfacing area of the soft magnetic material and the copper plate includes an insulating resin material.

Abstract: Disclosed in the present invention are a polyvinyl alcohol (PVA)-based degradable plastic, a preparation method therefor and application thereof, and a recycling method therefor. The preparation method comprises the following steps: a PVA solution is subjected to a chemical grafting reaction under an acidic condition under the action of a modifier; there are a phenyl group, an aldehyde group, and at least one group capable of forming a hydrogen bond with PVA in a structural formula of the modifier. The polyvinyl alcohol-based degradable plastic provided in the present invention has the advantages of being high in transparency, high in mechanical strength, not affected by environmental humidity, easy to degrade, good in thermal stability and good in biocompatibility, and has the advantages of recyclability, low costs, easy large-scale preparation and the like.

Abstract: A use of lactoferrin in the preparation of a food or drug, the food or drug being used for activating a VDR signaling pathway, which is used for the treatment of bone disease, bone disease comprising: osteoporosis, bone damage, loss of bone calcium, incomplete bone development and bone abnormalities. The present invention further comprises screening for drugs that are used to promote osteoblast proliferation and differentiation by using an active state of the VDR signaling pathway.